Mac Kenzie Cleve S MD is categorized under Ophthalmologists in Huntington Beach, CA and active since 1996.
Mac Kenzie Cleve S MD was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Cleve Mac Kenzie at the company’s single location by writing to 19582 Beach Boulevard # 322, Huntington Beach, California CA 92648 or by phoning (714) 965-9696. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mac Kenzie Cleve S MD |
Contact Person: | Cleve Mac Kenzie |
Address: | 19582 Beach Boulevard # 322, Huntington Beach, California 92648 |
Phone Number: | (714) 965-9696 |
Website Address: | beacheye.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1996 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Ophthalmologists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Mac Kenzie Cleve S MD was started in 1996 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Cleve Mac Kenzie for inquiries that concern Mac Kenzie Cleve S MD by calling the company number (714) 965-9696, as your correspondence is most welcome. Additionally, the physical location of the single location of Mac Kenzie Cleve S MD can be found at the coordinates 33.67844,-117.98847 as well as the street address 19582 Beach Boulevard # 322 in Huntington Beach, California 92648.
For its online presence, you may visit Mac Kenzie Cleve S MD’s website at beacheye.com and engage with its social media outlets through on Twitter and on Facebook.